Synthesis of 13, 492 Antisense Oligonucleotides (ASOs) for SARS-Cov2 Project
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- 75N95022Q00263
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
This pre-solicitation notice seeks responses for the synthesis of 13,492 antisense oligonucleotides targeting the SARS-CoV-2 viral genome. The National Institutes of Health National Institute on Drug Abuse intends to define an acquisition strategy for a forthcoming solicitation to have the oligonucleotides synthesized and delivered within three to four weeks of order receipt. Interested parties should submit responses to the contracting officer by May 30th identifying how their proposed products will meet requirements to deliver the specified oligonucleotides normalized to 10 nmol each in four 384-well plates hydrated in IDTE buffer.
There is no set-aside designated for this procurement. The NAICS code is 325414 for biological product manufacturing. Responses should include the organization's DUNS, address, point of contact, and small business size standard relative to this NAICS code. The intent is to have the oligonucleotides synthesized and delivered within three to four weeks of order receipt at an estimated quantity of 13,492 individual oligonucleotides across four 384-well plates.
Notice text
*Please see attached Sources Sought Notice*
Files
| File | Type | Posted |
|---|---|---|
| B Sources Sought.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Synthesis of 13, 492 Antisense Oligonucleotides (ASOs) for SARS-Cov2 Project | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - B2B Award entitled - Developing Red Cell-Sp | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity